Breaking News

Forge Biologics Launches FUEL Manufacturing Platform

Provides AAV gene therapy developers a more efficient and accelerated foundation for manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Forge Biologics, a member of Ajinomoto Bio-Pharma Services and a manufacturer of genetic medicines, has launched the FUEL manufacturing platform to provide AAV gene therapy developers a more efficient and accelerated foundation for manufacturing as they advance new programs and target a broader range of diseases.   The FUEL (Foundation for Unleashing Excellence in Life-Changing Therapies) platform introduces several new technical advancements. One of these advancements is Forge’s pEMBR 2.0 Ad ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters